NASDAQ
CLOV
Last Price
US $4.49
Valuation
Financial
Performance
Cash flow to debt coverage
Clover Health Investments, Corp. carries no debt; cash flow comfortably covers obligations.
Free cash flow growth
Clover Health Investments, Corp.'s free cash flow has decreased 307.21% from $33.29M last year to $-68.98M, signaling decreasing performance
Debt-to-equity ratio
Clover Health Investments, Corp.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
Clover Health Investments, Corp. has insufficient data to evaluate this check.
Net debt to EBITDA
Clover Health Investments, Corp. has a net cash position, so leverage is healthy.
Interest coverage
Clover Health Investments, Corp. carries no debt; interest obligations are fully covered.
Profit margin growth
Clover Health Investments, Corp.'s profit margin has increased (-76.36%) in the last year from -3.14% to -0.74%, signaling increasing performance
Current ratio
Clover Health Investments, Corp.'s short-term assets of $307.86M exceed its short-term liabilities of $208.82M
Return on assets
Clover Health Investments, Corp.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Clover Health Investments, Corp.'s return on equity of -5.38%, is lower than 15.00%, indicating bad performance
Earnings quality
Clover Health Investments, Corp.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Clover Health Investments, Corp. had positive net income in only 0 out of 5 years, indicating unstable earnings
Positive free cash flow
Clover Health Investments, Corp. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Clover Health Investments, Corp. has negative free cash flow, indicating cash burn
Earnings growth
Clover Health Investments, Corp.'s yearly earnings has decreased 98.91% since last year from $-43.01M to $-85.55M, signaling decreasing performance
Revenue growth
Clover Health Investments, Corp.'s yearly revenue has increased 40.34% since last year from $1.37B to $1.92B, signaling increasing performance
Return on invested capital
ROIC -4.62% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Clover Health Investments, Corp.'s 3-year revenue CAGR of 20.62% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Clover Health Investments, Corp. had revenue growth in 4 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Clover Health Investments, Corp. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity
Cash Flow Valuation (DCF)
Clover Health Investments, Corp. has insufficient data to evaluate this check.
Earnings yield (TTM)
Clover Health Investments, Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
Clover Health Investments, Corp. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
Clover Health Investments, Corp. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Clover Health Investments, Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Clover Health Investments, Corp. has a price-to-book ratio of 6.37x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Price-to-sales ratio (TTM)
Clover Health Investments, Corp. has a price-to-sales ratio of 0.97x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-5.38%
Return on equity
ROIC: -4.62%
Valuation History
-
Price to Earnings
EV/EBITDA: -129.3X
Cash flow
Profit margin
-1.26%
Cash flow
11.56%
Fair Value
Market $4.49
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.